AI played a significant role in the development of Rentosertib, a drug targeting idiopathic pulmonary fibrosis. The AI system identified TNIK as a novel target and optimized the molecular structure, compressing the discovery phase from several years to 18 months. However, AI was not involved in the clinical trial design, site management, or regulatory navigation. AI
IMPACT AI is demonstrating its capability to significantly shorten drug discovery timelines, potentially leading to faster development of treatments for complex diseases.
RANK_REASON The item describes the application of AI in drug discovery, specifically identifying a target and optimizing a molecule, which falls under research. [lever_c_demoted from research: ic=1 ai=1.0]
Read on Mastodon — fosstodon.org →
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
